摘要
结核病是全球主要的公共卫生问题之一,据世界卫生组织最新报道中国结核病发病人数排名全球第二,所以中国结核病疫情不容忽视。研究肺结核治疗结局的影响因素,将为今后肺结核的防治工作提供理论依据。为此本文研究肺结核治疗结局的影响因素进展。
引文
[1]World Health Organization.Global Tuberculosis report 2018.
[2]中华人民共和国卫生部疾病预防控制局,中华人民共和国卫生部医政司,中国疾病预防控制中心.中国结核病防治规划实施工作指南(2008年版)[M].北京:中国协和医科大学出版社,2008.
[3]TizazuZenebe,ErmiasTefera.Tuberculosis treatment outcome and associated factorsamong smear-positive pulmonarytuberculosis patients in Afar,Eastern Ethiopia:a retrospective study[J].Braz J Infect Dis,2016,20(6):635-636.
[4]Aylin Babal?k,Zeki K?l??aslan,?ule K?z?lta?,et al.A retrospective case-control study,factors affecting treatment outcomes for pulmonary tuberculosis in istanbul,Turkey[J].Balkan Med J,2013,30(2):204-210.
[5]吕静.武汉市硚口区登记肺结核病流行特征及治疗结局分析[D].华中科技大学硕士论文.2011.
[6]周银发,林淑芳,成玉妹,等.惠安县涂阳肺结核治疗转归特征及影响因素分析[J].海峡预防医学杂志,2016,22(6):27-29.
[7]杨智琪,胡屹,赵琦,等.徐州市两县和乌鲁木齐市涂阳肺结核患者疗效及其影响因素分析[J].中国防痨杂志,2018,40(1):98-105.
[8]Grzegorz Przybylski,Anita D?browska,Hanna Trzcińska.Alcoholism and other socio-demographic risk factors for adverse TB-drug reactions and unsuccessful tuberculosis treatment-data from ten years’observation at the Regional Centre of Pulmonology,Bydgoszcz,Poland[J].Med Sci Monit,2014,20:444-453.
[9]Bloss E,Chan PC,Cheng NW,et al.Increasing directly observed therapy related to improved tuberculosis treatment outcomes in Taiwan[J].Int J Tuberc Lung Dis,2012,16(4):462-467.
[10]Wang N,Ma Y,Liu YH,et al.Risk of Treatment Failure in Patients with Drug-susceptible Pulmonary Tuberculosis in China[J].Biomed Environ Sci,2016,29(8):612-617.
[11]Hongjo Choi,Myungsun Lee,Ray Y Chen.Predictors of pulmonary tuberculosis treatment outcomes in South Korea:a prospective cohort study,2005-2012[J].BMC Infect Dis,2014,14:360.
[12]王倪,杜建,马艳,等.涂阳肺结核患者治疗失败影响因素分析[J].中国防痨杂志,2016,38(6):450-455.
[13]何涛,汪峰,唐武.西部地区初治肺结核患者410例的治疗效果及影响因素分析[J].临床合理用药,2016,9(1A):23-26.
[14]Gebremedhin Gebrezgabiher,Gebremedhin Romha,Eyasu Ejeta,et al.Treatment Outcome of Tuberculosis Patients under Directly Observed Treatment Short Course and Factors Affecting Outcome in Southern Ethiopia:A Five-Year Retrospective Study[J].PLoSONE,2016,11(2):e0150560.
[15]Aishatu Lawal Adamu,Muktar H.Aliyu,Najiba Aliyu Galadanci,et al.The impact of rural residence and HIV infection on poor tuberculosis treatment outcomes in a large urban hospital:a retrospective cohort analysis[J].Int JEquity Health,2018,17:4.
[16]Madeeha Laghari,Syed Azhar Syed Sulaiman,Amer Hayat Khan,et al.Epidemiology of tuberculosis and treatment outcomes among children in Pakistan:a 5 year retrospective study[J].PeerJ,2018,6:e5253.
[17]云静,王爱民.146例血行播散性肺结核患者的临床特点及疗效影响因素分析[J].中国病案,2016,17(12):70-73.
[18]Eyasu Ejeta,Conceptualization,Data curation,et al.Factors associated with unsuccessful treatment outcome in tuberculosis patients among refugees and their surrounding communities in Gambella Regional State,Ethiopia[J].PLoSOne,2018,13(10):e0205468.
[19]宋燕芹,张锡林,钟永辉,等.佛山市老年肺结核疗效影响因素分析[J].国际老年医学杂志,2018,39(4):187-189.
[20]王倪,马艳,杜建,等.涂阳肺结核患者并发糖尿病对疗效和治疗转归的影响因素研究[J].中国防痨杂志,2016,38(10):843-849.
[21]钟远芹,劳长娣,范书艳,等.矽肺合并肺结核患者临床疗效与相关影响因素分析[J].吉林医学,2017,38(1):119-121.
[22]Ali Nasir Siddiqui,Khalid Umer Khayyam,Manju Sharma.Effect of Diabetes Mellitus on Tuberculosis Treatment Outcome and Adverse Reactions in Patients Receiving Directly Observed Treatment Strategy in India:AProspective Study[J].Biomed Res Int,2016,2016:7273935.
[23]Senedu Bekele Gebreegziabher,Gunnar Aksel Bjune,Solomon Abebe Yimer.Total Delay Is Associated with Unfavorable Treatment Outcome among Pulmonary Tuberculosis Patients in West Gojjam Zone,Northwest Ethiopia:A Prospective Cohort Study[J].PLoS ONE,2016,11(7):e0159579.
[24]Biniam Wondale,Girmay Medihn,Takele Teklu,et al.A retrospective study on tuberculosis treatment outcomes at Jinka General Hospital,southern Ethiopia[J].BMC Res Notes,2017,10(1):680.
[25]van Altena R,de Vries G,Haar CH,et al.Highly successful treatment outcome of multidrug-resistant tuberculosis in the Netherlands,2000-2009[J].Int J Tuberc Lung Dis,2015,19(4):406-412.
[26]Khaing PS,Kyaw NTT,Satyanarayana S,et al.Treatment outcome of tuberculosis patients detected using accelerated vs.passive case finding in Myanmar[J].Int J Tuberc Lung Dis,2018,22(10):1145-1151.
[27]Falvo JV,Ranjbar S,Jasenosky LD,et al.Arc of a Vicious Circle:Pathways Activated by Mycobacterium tuberculosis That Target the HI.V-1 Long Terminal Repeat[J].Am J Respir Cell Mol Biol,2011,45(6):1116-1124.
[28]Kelemework Adane,Mark Spigt,Geert-Jan Dinant.Tuberculosis treatment outcome and predictors in northern Ethiopian prisons:a five-year retrospective analysis[J].BMC Pulm Med,2018,18(1):37.
[29]Setegn Eshetie,Mucheye Gizachew,,Animut Alebel,et al.Tuberculosis treatment outcomes in Ethiopia from 2003 to 2016,and impact of HIV coinfection and prior drug exposure:A systematic review and meta-analysis[J].PLoS One,2018,13(3):e0194675.
[30]黄莉,许琳,杨蕊,等.云南省2010-2013年HIV阳性结核病患者抗结核疗效影响因素[J].中国公共卫生,2017,33(3):357-360.
[31]张玲.耐多药肺结核治疗及其影响因素分析[J].临床肺科杂志,2016,21(8):1508-1511.
[32]Eshetie S,Gizachew M,Dagnew M,et al.Multidrug resistant tuberculosis in Ethiopian settings and its association with previous history of antituberculosis treatment:a systematic review and meta-analysis[J].BMC infect Dis,2017,17(1):219.